Patients Who Refuse Blood Transfusions Should Not Be Discouraged from Immediate Direct-to-Implant Breast...

Area of Science:

• Oncology
• Plastic Surgery
• Surgical Outcomes

Background:

• Direct-to-implant (DTI) breast reconstruction is a common immediate breast restoration method post-mastectomy.
• DTI reconstruction improves quality of life without compromising oncological outcomes.
• Its safety in patients refusing blood transfusions is not well-established.

Purpose of the Study:

• To evaluate the safety of mastectomy with direct-to-implant breast reconstruction (M-DTI) in terms of bleeding complications.
• To compare bleeding risks between mastectomy alone (MA) and M-DTI.

Main Methods:

• Retrospective review of 490 patients undergoing MA or M-DTI from January 2021 to June 2023.
• Analysis of patient demographics, surgical details, and bleeding complication rates.
• Comparison of complication rates between the two surgical groups.

Main Results:

• Bleeding complications occurred in 2.4% of MA patients and 1.8% of M-DTI patients (p=0.249).
• No significant difference in bleeding risk was observed between MA and M-DTI.
• Severe bleeding risk was independent of patient age, diagnosis, or procedure type.

Conclusions:

• Immediate breast reconstruction following mastectomy does not elevate bleeding risks.
• Mastectomy with direct-to-implant reconstruction is a safe and viable option for patients requiring bloodless medicine.
• This approach supports patient choice and quality of life without compromising safety.